| Financial Year |
March 31 2023 |
| Monetary Funds |
129,477,295.44 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,173,203.00 |
| Advances to Suppliers |
23,517,371.54 |
| Other Receivables |
2,329,209.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
148,717,235.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,518,713.63 |
| Total Current Assets |
314,733,028.71 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
475,889,017.84 |
| Investment Properties |
-- |
| Fixed Assetes |
1,589,566,196.42 |
| Under-construction Projects |
763,812,775.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,108,056,804.85 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
487,868.34 |
| Deferred Income Tax Assets |
21,964,208.90 |
| Other Non-Current Assets |
22,717,411.08 |
| Sub-Total of Non-Current Assets |
4,990,242,322.33 |
| Total Assets |
5,304,975,351.04 |
| Short-Term Loans |
115,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
180,000,000.00 |
| Accounts Payable |
313,682,665.58 |
| Accounts Received In Advance |
46,933.33 |
| Employee Compensation Payable |
10,604,776.09 |
| Taxes Payable |
14,550,112.58 |
| Interest Payable |
2,857,416.19 |
| Dividend Payable |
-- |
| Other payables |
289,543,502.14 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
86,302,365.70 |
| Other Current Liabilities |
9,865,574.46 |
| Sub-Total of Current Liabilities |
1,107,815,940.04 |
| Long-term Loans |
234,765,439.82 |
| Bonds Payable |
220,869,776.14 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
78,204,417.46 |
| Deferred Income Tax Liabilities |
114,302,663.61 |
| Other Non-Current Liabilities |
11,739,078.82 |
| Sub-Total of Non-Current Liabilities |
686,547,005.83 |
| Total Liabilities |
1,794,362,945.87 |
| Paid-In Capital(Or Share Stock) |
562,330,466.00 |
| Capital Surplus |
704,164,368.87 |
| Surplus Reserve |
196,748,943.75 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,384,650,531.34 |
| Minority Stockholder's Interest |
627,940,366.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,882,672,038.95 |
| Owner's Equity（Stockholder's Equity） |
3,510,612,405.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,304,975,351.04 |
